Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1990 Jul-Aug;5(4):275-85.
doi: 10.2165/00002018-199005040-00004.

Adverse reactions and interactions with theophylline

Affiliations
Review

Adverse reactions and interactions with theophylline

M H Skinner. Drug Saf. 1990 Jul-Aug.

Abstract

Despite the trend towards newer therapeutic agents, theophylline continues to play a major role in the treatment of reversible airway obstruction. Clinical use of the drug is complicated by a relatively narrow therapeutic range and a large pharmacokinetic variability between patients. Generally, however, theophylline toxicity is foreseeable and preventable. Most cases can be attributed to either inadvertent or intentional overdosing of the drug. Age, disease state and drug interactions are other factors which may contribute to its toxicity. Nausea, vomiting and tachycardia are common signs of mild theophylline toxicity; seizures, ventricular arrhythmias and hypotension are life-threatening manifestations of severe toxicity which may respond poorly to standard therapy. Although serum theophylline concentration correlates with toxicity in a general fashion, life-threatening adverse reactions are not readily predictable from the drug concentration alone. Treatment of theophylline toxicity primarily involves supportive care along with gastric lavage and administration of activated charcoal to facilitate drug removal. The early use of haemoperfusion may be life-saving in cases of severe toxicity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1981 Feb;29(2):224-9 - PubMed
    1. Chest. 1986 Jul;90(1):45-51 - PubMed
    1. Lancet. 1984 Jul 14;2(8394):108-9 - PubMed
    1. N Engl J Med. 1982 Aug 26;307(9):557-8 - PubMed
    1. Clin Pharmacol Ther. 1988 Jul;44(1):35-8 - PubMed

LinkOut - more resources